Table 2.
Week of treatment | Weight loss not on target, N (%) | Weekly attendance, N (%) | Drop-out, N (%) | Clinically significant weight loss at 6 months, by early-treatment weight loss | |||||
---|---|---|---|---|---|---|---|---|---|
Se, % | Sp, % | 5% or greater weight loss at 6 months among those whose early-treatment weight loss was on target N (%) | 5% or greater weight loss at 6 months among those whose early-treatment weight loss was not on target N (%) | Crude RR (95% CI) | Adjusted RR (95% CI) | ||||
Week 2 | 33 (44) | 65 (87) | 2 (3) | 56 | 72 | 23 (55) | 9 (27) | 2.01 (1.08–3.74) | 2.40 (2.32–4.35)a |
Week 3 | 32 (43) | 64 (85) | 5 (7) | 53 | 72 | 23 (54) | 9 (28) | 1.90 (1.02–3.54) | 2.32 (1.25–4.29)b |
Week 4 | 35 (47) | 58 (77) | 7 (9) | 60 | 72 | 23 (58) | 9 (26) | 2.24 (1.20–4.17) | 2.02 (1.05–3.92)c |
Week 5 | 40 (53) | 54 (72) | 7 (9) | 70 | 69 | 22 (63) | 10 (25) | 2.51 (1.39–4.55) | 2.51 (1.39–4.55) |
Week 6 | 44 (59) | 54 (69) | 7 (9) | 77 | 66 | 21 (68) | 11 (25) | 2.71 (1.54–4.77) | 2.71 (1.54–4.77) |
Week 7 | 45 (60) | 48 (64) | 7 (9) | 77 | 63 | 20 (67) | 12 (27) | 2.50 (1.45–4.32) | 2.85 (1.60–5.09)d |
Week 8 | 47 (63) | 52 (69) | 8 (11) | 84 | 66 | 21 (75) | 11 (23) | 3.20 (1.83–5.61) | 3.20 (1.83–5.61) |
Se: sensitvity, i.e., proportion of women failing to achieve 5% or greater weight loss at 6 months who were not on target with their weight loss at a given week early in treatment; Sp: specificity, i.e., proportion of women achieving 5% or greater weight loss at 6 months who were on target with their weight loss at a given week early in treatment.
Adjusted for BMI category (class II or III obesity versus overweight or class I obeisty) at treatment initiation;
Adjusted for BMI (continuous) at treatment initiation;
Adjusted for education (categories);
Adjusted for smoking (never versus former smoking)